Drugs Made In America Acquisition (DMII) Cash & Equivalents (2024 - 2025)
Drugs Made In America Acquisition (DMII) posted quarterly Cash & Equivalents of $223.0 for Q4 2025, down 98.69% year-over-year from $17035.0 in Q4 2024, and down 99.93% quarter-over-quarter from $315087.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Cash & Equivalents (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Cash & Equivalents for 2 consecutive years, with $223.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Equivalents fell 98.69% year-over-year to $223.0; the TTM figure through Dec 2025 stood at $223.0 (down 98.69% YoY), while the FY2025 annual figure was $223.0, down 98.69% from the prior year.
- Cash & Equivalents slipped to $223.0 in Q4 2025 per DMII's latest filing, from $315087.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $315087.0 in Q3 2025 and bottomed at $223.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 816,134.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 250,000.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 174,974.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 25,000.00 |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 10,586.00 |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 283,112.00 |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 735,027.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 194,541.00 |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 250,000.00 |
| 10 | CSLM Digital Asset Acquisition Corp III | 322.52 Mn | 314.90 Mn | - | 2.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 315,087.00 |
| Dec 31, 2024 | 17,035.00 |